Early success of anti-HIV preventive oral drug regimen is promising, but questions remain
Monday, March 14, 2011 - 17:30
in Health & Medicine
The first human studies of an oral drug regimen to prevent HIV infection in high-risk individuals yielded a promising near 50 percent reduction in HIV incidence, but a number of issues require additional research before oral pre-exposure prophylaxis can be implemented on a large scale, according to an article in AIDS Patient Care and STDs, a peer-reviewed journal published by Mary Ann Liebert Inc.